No products in the cart.

Hero MCM-04 Reishi vs chaga
Home/ Compare/ Reishi vs Chaga

Reishi vs Chaga: Species, Compounds and What Trials Measured

Reishi is Ganoderma lucidum, and the part used is the fruiting body, which holds two chemically separate fractions: beta-glucans that need hot water and triterpenoids called ganoderic acids that need alcohol. Chaga is the sterile conk of Inonotus obliquus, a hardened black growth of fungus and birch wood rather than a fruiting body.
Reishi has a handful of small randomised trials. Chaga has none, and three published cases link it to oxalate kidney damage.

Third Party Tested Batch Certificates Of Analysis Highest Quality Full Spectrum Global Shipping 100% Organic
Third Party Tested Batch Certificates Of Analysis Highest Quality Full Spectrum Global Shipping 100% Organic

At a glance

Property
Reishi
Chaga
Species
Ganoderma lucidum, known as lingzhi, a bracket fungus of hardwood.
Inonotus obliquus, a parasite of birch in the Hymenochaetaceae.
Part used
The fruiting body, the fan-shaped bracket on the trunk.
The sterile conk: fungal tissue fused with birch, not a fruiting body.
Key measured compounds
Beta-glucans and ganoderic acid triterpenoids.
Glucans, chlorogenic acid, inotodiol, melanin and oxalate.
Beta-glucan content
47.5% to 55.9% of dry weight, across 6 strains and 5 substrates.
Total glucan between 0.62 and 20.95 g per 100 g, by solvent.
Extraction method needed
Two solvents: hot water for beta-glucans, alcohol for triterpenoids.
Subcritical water at 200 degrees Celsius gave 20 times the beta-glucan of ethanol.
Traditional use context
Named lingzhi in Chinese materia medica for roughly 2,000 years.
A folk decoction across Siberian birch country, also smoked.
Human trials
5 randomised cancer trials and 5 cardiovascular trials, pooled by Cochrane.
No randomised controlled trial of chaga has been published.
What the evidence does not show
No pooled trial recorded long-term cancer survival.
No human outcome data; published work is laboratory, rodent or case report.
Endoca product
Endoca Red Reishi Mushroom Extract, organic capsules, 1 daily.
Endoca Chaga Mushroom Extract, 370 mg per capsule, 1 daily.

What these two actually are

Start with the part used, because the two are not the same kind of thing. Reishi is a fruiting body: the bracket that forms on hardwood is the reproductive structure of Ganoderma lucidum. Chaga is a conk. Inonotus obliquus produces a true fruiting body only briefly, under the bark of a dying birch, and the black material sold as chaga is sterile tissue, fungal hyphae grown through the wood of the colonised tree.
That shapes the chemistry. Fruiting body tissue is mostly fungal cell wall, which is why beta-glucan assays return large figures from reishi. A conk is a mixture: melanin pigment, triterpenes taken up from birch, phenolic acids, and oxalate at the levels recorded in kidney injury cases.
It also shapes what a certificate can report. Reishi can be described by beta-glucan, calculated as total glucan minus alpha-glucan, and by a triterpene figure. Chaga is better described by glucan, phenolics and oxalate. Across this category the usual quality question is fruiting body or mycelium grown on grain, and for chaga the first question is whether the material is conk at all.

Beta-glucans, and why the number on the label may not mean what you think

MCM-04 Reishi vs chaga second section

Beta-glucan is not measured directly. The accepted enzymatic assay reads total glucan, reads alpha-glucan separately, and gives beta-glucan as the difference. Starch is why that subtraction exists: a crude polysaccharide figure counts alpha-glucan too, so grain substrate carried into a finished powder lifts the headline number without adding beta-glucan.
The genuine figure also shifts with how the mushroom was grown. Ganoderma lucidum fruiting bodies raised on sawdust and chips from five tree species returned 47.5 to 55.9 percent beta-glucan of dry weight on that assay, lowest on pine and highest on aspen. An 8 point spread inside one species, in one laboratory, is the context a single label figure is missing.
Solvent decides the rest. Reishi’s ganoderic acids are lipophilic and come out in alcohol, its beta-glucans are water soluble and come out in hot water, so one extraction returns one fraction. Chaga shows the same effect in numbers: subcritical water at 200 degrees Celsius gave total glucan of 20.4 and 20.9 g per 100 g from two chaga samples, against 0.62 to 1.13 g per 100 g from microwave or ultrasound extraction in 96 percent ethanol.

What the human evidence shows

Reishi
Pooling 5 randomised trials, a Cochrane review recorded tumour response more often when G. lucidum accompanied chemotherapy or radiotherapy, relative risk 1.50, 95 percent CI 0.90 to 2.51.
None of those 5 trials recorded long-term survival, and the reviewers judged the methodological quality of the primary studies unsatisfactory.
A separate Cochrane review recorded no change in HbA1c across 130 participants at 1.4 to 3 g daily, weighted mean difference minus 0.10 percent, 95 percent CI minus 1.05 to 0.85, and none in cholesterol, LDL cholesterol or body mass index across 107.
Chaga
No randomised controlled trial of any chaga preparation has been published, for any outcome or population.
The human chaga record is three case reports of oxalate nephropathy after months to years of chaga powder, all three requiring haemodialysis, with renal function recovering in only one.
An inotodiol-rich chaga extract raised spontaneous alternation in a Y-maze test in transgenic mice, a rodent measurement with no human equivalent.

The gap is not subtle. Reishi’s one positive pooled estimate has an interval crossing no effect, and its glucose and lipid outcomes came back flat. Chaga has no randomised human literature of any kind, and its only human records are kidney injuries.

What people get wrong

01 Chaga is a mushroom.
It is a sterile conk, hardened fungal tissue fused with birch wood on a standing tree. The true fruiting body of Inonotus obliquus forms only briefly under the bark.
02 A high polysaccharide figure means a strong extract.
A polysaccharide figure counts alpha-glucan, and on a grain-grown product that is mostly substrate starch. Beta-glucan is the difference between total glucan and alpha-glucan, where an inflated figure falls apart.
03 Centuries of use make chaga safe.
Three published case reports describe oxalate nephropathy after chaga powder, all three requiring haemodialysis, with renal function recovering in only one. One powder analysed in those reports held 0.14 g of oxalate per gram.

Choosing between them

Reishi is the one with trials: small, clustered in one region and rated poor quality by two Cochrane reviews, with no long-term survival data. If reishi is the choice, look for an extract made with both hot water and alcohol. Chaga has no trial to set against the three kidney injury case reports. Anyone with kidney stones, reduced kidney function or an already high oxalate intake should avoid chaga and speak to a clinician first. Neither carries an authorised claim in Great Britain, so compare them on species, part used, solvent and measured content.

How Endoca tests for this

A certificate of analysis sits behind each Endoca mushroom extract, and the quality programme runs pesticide, heavy metal and mycotoxin screening to GMP standards with third party verification. Three figures are missing from it: a beta-glucan percentage, a triterpene content and an oxalate result. For chaga the oxalate figure is the one worth requesting rather than assuming. Endoca works from its own farm, own land and own extraction, since 2010.

Frequently asked questions

Not strictly. Chaga as sold is the sterile conk of Inonotus obliquus: a hard black mass of hyphae grown through birch wood. A true fruiting body does form, briefly and under the bark of a dying tree, but it is not what reaches supplements.

Reishi, although the baseline is low. Two Cochrane reviews pooled 5 randomised trials in cancer patients and 5 in cardiovascular risk, and rated the primary studies poor. No randomised controlled trial of chaga in humans has been published for any outcome.

Its two compound groups need different solvents. The beta-glucans dissolve in water and are drawn out by a hot water decoction. Ganoderic acid triterpenoids are lipophilic and come out in alcohol. A water-only extract is low in triterpenoids, an alcohol-only tincture low in beta-glucans.

One powder analysed in a published case report contained 0.14 g of oxalate per gram, around 14 g per 100 g. Three case reports describe oxalate nephropathy after prolonged chaga intake, all three requiring haemodialysis, with renal function recovering in only one. Case reports cannot establish frequency.

References

01

Cortina-Escribano M, Pihlava JM, Miina J, Veteli P, Linnakoski R, Vanhanen H. Effect of strain, wood substrate and cold treatment on the yield and beta-glucan content of Ganoderma lucidum fruiting bodies. Molecules. 2020;25(20):4732.

02

McCleary BV, Draga A. Measurement of beta-glucan in mushrooms and mycelial products. J AOAC Int. 2016;99(2):364-373.

03

Jin X, Ruiz Beguerie J, Sze DM, Chan GC. Ganoderma lucidum (Reishi mushroom) for cancer treatment. Cochrane Database Syst Rev. 2016;(4):CD007731.

04

Klupp NL, Chang D, Hawke F, Kiat H, Cao H, Grant SJ, Bensoussan A. Ganoderma lucidum mushroom for the treatment of cardiovascular risk factors. Cochrane Database Syst Rev. 2015;(2):CD007259.

05

Lazic V, Lazic V, Klaus A, Kozarski M, Doroski A, Tosti T, Simic S, Vunduk J. The effect of green extraction technologies on the chemical composition of medicinal chaga mushroom extracts. J Fungi (Basel). 2024;10(3):225.

06

Lee S, Lee HY, Park Y, Ko EJ, Ban TH, Chung BH, Lee HS, Yang CW. Development of end stage renal disease after long-term ingestion of chaga mushroom: case report and review of literature. J Korean Med Sci. 2020;35(19):e122.

07

Kikuchi Y, Seta K, Ogawa Y, Takayama T, Nagata M, Taguchi T, Yahata K. Chaga mushroom-induced oxalate nephropathy. Clin Nephrol. 2014;81(6):440-444.

08

Kwon O, Kim Y, Paek JH, Park WY, Han S, Sin H, Jin K. Chaga mushroom-induced oxalate nephropathy that clinically manifested as nephrotic syndrome: a case report. Medicine (Baltimore). 2022;101(10):e28997.

09

Ban S, Do TT, Pyo JW, Moon M, Park JT. INO10, a chaga mushroom extract, alleviates Alzheimer’s disease-related pathology and cognitive deficits in 3xTg-AD mice. Int J Mol Sci. 2025;26(10):4729.

10

Regulation (EU) No 432/2012 establishing a list of permitted health claims made on foods, Annex, beta-glucans entries, as it applies in Great Britain.

Last reviewed 1 October 2026.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.